Your browser doesn't support javascript.
loading
Exposure to acetaminophen and all its metabolites upon 10, 15, and 20 mg/kg intravenous acetaminophen in very-preterm infants.
Flint, Robert B; Roofthooft, Daniella W; van Rongen, Anne; van Lingen, Richard A; van den Anker, Johannes N; van Dijk, Monique; Allegaert, Karel; Tibboel, Dick; Knibbe, Catherijne A J; Simons, Sinno H P.
Affiliation
  • Flint RB; Department of Pediatrics, Division of Neonatology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Roofthooft DW; Department of Pharmacy, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • van Rongen A; Department of Pharmacy, Radboudumc, Nijmegen, The Netherlands.
  • van Lingen RA; Department of Pediatrics, Division of Neonatology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • van den Anker JN; Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, The Netherlands.
  • van Dijk M; Division of Pharmacology, Leiden Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands.
  • Allegaert K; Division of Neonatology, Department of Pediatrics Princess Amalia, Isala Clinics, Zwolle, The Netherlands.
  • Tibboel D; Intensive Care and Department of Pediatric Surgery, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Knibbe CAJ; Division of Clinical Pharmacology, Children's National Health System, Washington, DC, USA.
  • Simons SHP; Division of Pediatric Pharmacology and Pharmacometrics, University of Basel Children's Hospital, Basel, Switzerland.
Pediatr Res ; 82(4): 678-684, 2017 Oct.
Article in En | MEDLINE | ID: mdl-28553988
ABSTRACT
BackgroundExposure to acetaminophen and its metabolites in very-preterm infants is partly unknown. We investigated the exposure to acetaminophen and its metabolites upon 10, 15, or 20 mg/kg intravenous acetaminophen in preterm infants.MethodsIn a randomized trial, 59 preterm infants (24-32 weeks' gestational age, postnatal age <1 week) received 10, 15, or 20 mg/kg acetaminophen intravenously. Plasma concentrations of acetaminophen and its metabolites (glucuronide, sulfate, cysteine, mercapturate, and glutathione) were determined in 293 blood samples. Area under the plasma concentration-time curves (AUC0-500 min) was related to dose and gestational age.ResultsBetween 10 and 20 mg/kg dose, median AUCs of acetaminophen, glucuronide, sulfate, and cysteine increased significantly resulting in unchanged ratios of AUC of metabolite to acetaminophen. The AUC ratio of glucuronide to acetaminophen increased with gestational age, that of sulfate decreased, and the ratio of cysteine and mercapturate remained unchanged.ConclusionWe found a gestational-age-dependent increase in glucuronidation but no evidence for saturation of a specific pathway as there was a proportional increase in exposure of acetaminophen and all metabolites. Compared with adults, very low exposure to glucuronide but higher exposure to sulfate, cysteine, and mercapturate metabolites was found, of which the relevance is not yet known.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Analgesics, Non-Narcotic / Infant, Extremely Premature / Acetaminophen Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Newborn Country/Region as subject: Europa Language: En Journal: Pediatr Res Year: 2017 Document type: Article Affiliation country: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Analgesics, Non-Narcotic / Infant, Extremely Premature / Acetaminophen Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Newborn Country/Region as subject: Europa Language: En Journal: Pediatr Res Year: 2017 Document type: Article Affiliation country: Países Bajos